Full-Time

Research Associate 2

Services

Cellanome

Cellanome

51-200 employees

Automated platform for live single-cell assays

Compensation Overview

$75k - $85k/yr

+ Stock options

San Diego, CA, USA

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Cell Biology

Get referred to Cellanome

See people who can refer or advise you

Requirements
  • A Bachelor's degree in cell biology, molecular biology, or a related field is required.
  • At least 2 years of experience working in a laboratory environment is required.
  • Hands-on experience with cell culture techniques and assays is required.
  • Experience with laboratory automation and laboratory information management systems is required; Hamilton experience is a plus.
  • The ability to follow protocols precisely and maintain strong attention to detail is required.
  • The ability to collaborate effectively with colleagues and communicate clearly is required.
  • The ability to perform the essential duties with or without reasonable accommodation is required.
  • The ability to lift up to 20 pounds for approximately 15% of a typical working day is required.
  • The ability to grasp with both hands, pinch with the thumb and forefinger, turn with the hand or arm, and reach above shoulder height is required.
  • The ability to comply with personal protective equipment requirements is required.
Responsibilities
  • Process samples end to end by preparing and assessing cells, setting up and monitoring instrument runs, overseeing automated library preparation, and performing final library quality control.
  • Follow standard operating procedures precisely and document all steps, observations, and deviations in the laboratory information management system in real time.
  • Support troubleshooting with the laboratory development and other internal teams.
  • Improve existing processes by providing feedback and ideas to the laboratory information management system and laboratory development teams.
  • Onboard and execute new processes transferred from the development team as the service menu expands.
  • Follow laboratory safety protocols and maintain a clean and organized work environment.
Desired Qualifications
  • Experience with Hamilton laboratory automation is preferred.

Cellanome provides an automated platform for live-cell phenotypic and functional assays that analyze single cells at scale. It runs high-throughput experiments that integrate with existing lab workflows, collecting multi-parameter data and allowing iterative testing under different conditions. The system emphasizes single-cell granularity, scalable data collection, and easy assay customization without major process changes. Its goal is to help life sciences, medical research, pharmaceutical, and biotech teams gain deeper cellular insights to accelerate discovery through a platform-as-a-service model.

Company Size

51-200

Company Stage

Series C

Total Funding

$276.9M

Headquarters

Foster City, California

Founded

2020

Get referred to Cellanome

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Psomagen added the R3200 on March 26, 2026, validating external demand.
  • Cellanome showcased live-cell analysis marrying imaging and sequencing at AGBT 2026.
  • Cellanome raised $75.9 million on June 22, 2026, extending runway.

What critics are saying

  • 10x Genomics and other single-cell vendors already dominate adjacent workflows.
  • Cellanome still lacks proof of broad customer adoption beyond Psomagen and conferences.
  • If 2026 spending misses hardware sales, the platform becomes an expensive science project.

What makes Cellanome unique

  • Cellanome links longitudinal live-cell imaging to single-cell transcriptomics from the same cells.
  • Its CellCage micro-3D-printed enclosures isolate cells while drugs and antibodies flow.
  • R3200 captures morphology, phenotype, and RNA on identical live cells.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Stock Options

401(k) Retirement Plan

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

58%

2 year growth

0%
U.S. Securities and Exchange Commission
Jul 17th, 2026
EDGAR Filing Documents for 0000905148-26-003005

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231Type: D | Act: 33 | File No.: 021-588010 | Film No.: 261104659

Intelligence360 News
Jul 17th, 2026
Cellanome files to raise $75.9M for live-cell imaging and single-cell transcriptomics platform

Cellanome has filed a notice with the US Securities and Exchange Commission to raise up to $75.9 million in new funding. The filing was made under Regulation D of the Securities Act of 1933, which allows companies to sell securities without full registration. The company develops technologies that combine longitudinal live-cell imaging with single-cell transcriptomics from the same cells. This approach enables scientists to capture cellular dynamics over time and connect cellular behaviour with molecular state. Researchers can access Cellanome's technology by implementing its R3200 platform in their laboratories, using its assay services, or collaborating with the company's scientists on new applications.

The Business Journals
Jan 30th, 2024
Peninsula startup with Illumina roots lands $150 million to peer deeper into cells

A Peninsula startup launched by top former Illumina execs raises $150 million to help researchers see what happens when cells dance with each other.

The Business Journals
Dec 8th, 2021
Former Illumina execs, Grail co-founder raise $21M for biotech startup

Biotech A-listers have come together to launch a new venture. What's it targeting? They're not saying.